CHRONIC GRAFT VERSUS HOST DISEASE

Clinical trials for CHRONIC GRAFT VERSUS HOST DISEASE explained in plain language.

Never miss a new study

Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear

Sign up with your email to follow new studies for CHRONIC GRAFT VERSUS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 16 Not yet recruiting 1 Not yet finished but already full! 15 Completed 3 Terminated 2

New drug safety check for transplant complication in india

Disease control Not yet recruiting

This study aims to check the safety of the drug belumosudil in Indian patients aged 12 and older who have chronic graft-versus-host disease (cGVHD) after a stem cell transplant. Participants will take the drug for up to 24 weeks and be monitored for side effects. The study will a…

Matched conditions: CHRONIC GRAFT VERSUS HOST DISEASE

Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control

Last updated Apr 01, 2026 20:26 UTC

CHRONIC GRAFT VERSUS HOST DISEASE

Get alerted when new CHRONIC GRAFT VERSUS HOST DISEASE trials appear

New drug safety check for transplant complication in india